Latest Breaking News On - Zai lab limited - Page 1 : vimarsana.com

Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipalertinib

CAMBRIDGE, Mass., June 01, 2024 Cullinan Therapeutics, Inc. , a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced positive initial data in.

Virginia
United-states
Cambridge
Cambridgeshire
United-kingdom
Chad
American
Rose-weldon
Jeffrey-jones
Jeff-jones
Alexander-spira
Globenewswire-inc

Cullinan Therapeutics, Inc. Announces Positive Initial Data from Pivotal Phase 2b Rezil1 Study of Zipalertinib

Cullinan Therapeutics, Inc. announced positive initial data in patients receiving zipalertinib after prior treatment with amivantamab enrolled in its pivotal Phase 2b REZILIENT1 clinical trial. As of.

Taiho-oncology-inc
Cullinan-therapeutics-inc
Greater-china-to-zai-lab
Taiho-pharmaceutical-co
Cullinan-therapeutics-inc-pearl-corp
Cullinan-therapeutics
Breakthrough-therapy-designation
Taiho-oncology
Taiho-pharmaceutical
Inc-cullinan-pearl-corp
Greater-china

Zai Lab (NASDAQ:ZLAB) Shares Gap Down to $18.46

Zai Lab Limited (NASDAQ:ZLAB – Get Free Report) shares gapped down prior to trading on Wednesday . The stock had previously closed at $18.46, but opened at $17.73. Zai Lab shares last traded at $17.83, with a volume of 35,690 shares. Analyst Upgrades and Downgrades Separately, Citigroup reduced their target price on Zai Lab from […]

Wellington
New-zealand-general
New-zealand
Frazor-titus-edmondson
Joshual-smiley
Janus-henderson-group
News-ratings-for-zai-lab-daily
Zai-lab
Hedge-funds-weigh-in-on-zai-lab
Wellington-management-group
G-plc
Citigroup

Here's Why Zai Lab Limited (ZLAB) Fell in Q1

Baron Funds, an investment management company, released its “Baron Emerging Markets Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.

China
Chinese
Microsoft
Us-congress
Zai-lab
Baron-emerging-markets-fund
Zai-lab-limited
Baron-funds
Emerging-markets
Institutional-shares
Proxy-benchmark

Zai Lab begins topical IL-17 trial for mild to moderate psoriasis

Zai Lab begins topical IL-17 trial for mild to moderate psoriasis
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Harald-reinhart
Kristen-dowd
Zai-lab
Lab-limited
Industry-news
Zai-lab-limited

Zai Lab Initiates Global Phase 2 Clinical Trial Evaluating ZL-1102 As a Topical Treatment for Chronic Plaque Psoriasis

Zai Lab Initiates Global Phase 2 Clinical Trial Evaluating ZL-1102 As a Topical Treatment for Chronic Plaque Psoriasis
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

China
United-states
Josh-smiley
Harald-reinhart
Zai-lab-forward
Zai-lab
Exchange-commission
Zai-lab-limited
Head-of-global-development
Chief-operating-officer
Global-development
Infectious-diseases

Zai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO® (Sulbactam-Durlobactam or SUL-DUR) for Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Acinetobacter Baumannii-Calcoaceticus Complex in China

Drug-resistant Acinetobacter baumannii is a growing global health threat and high priority pathogen needing new antibiotics, according to World Health Organization China NMPA approval based on.

Japan
Macau
Laos
Philippines
Hong-kong
Cambodia
Taiwan
New-zealand
Vietnam
Republic-of
Indonesia
Australia

Innoviva : Zai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO® (Sulbactam Durlobactam or SUL DUR) for Hospital Acquired and Ventilator Associated Pneumonia Caused by Acinetobacter Baumannii Calcoaceticus Complex in China

Innoviva : Zai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO® (Sulbactam Durlobactam or SUL DUR) for Hospital Acquired and Ventilator Associated Pneumonia Caused by Acinetobacter Baumannii Calcoaceticus Complex in China
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

China
Japan
Laos
Hong-kong
United-states
Shanghai
Philippines
Indonesia
Thailand
Cambodia
New-zealand
Malaysia

Zai Lab Limited (NASDAQ:ZLAB) Insider Frazor Titus Edmondson III Sells 10,000 Shares of Stock

Zai Lab Limited (NASDAQ:ZLAB) Insider Frazor Titus Edmondson III Sells 10,000 Shares of Stock
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

China
Frazor-titus-edmondson
China-universal-asset-management-co
Td-asset-management-inc
News-ratings-for-zai-lab-daily
Zai-lab-limited
Shell-asset-management-co
Zai-lab
Zai-lab-stock-down
Quarter-for-zai-lab
Mirae-asset-global-investments-co
Citigroup

Zai Lab Announces Participation in May and June Investor Conferences

Zai Lab Announces Participation in May and June Investor Conferences
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Miami-beach
Florida
United-states
New-york
China
Shanghai
Zai-lab-limited
Zai-lab
Panel-discussion
Goldman-sachs
Annual-global-china-summit